Aging is the single greatest risk factor for developing Alzheimer’s disease, Parkinson’s disease, and other brain diseases. It slows down your body’s ability to repair itself, leaving your heart, bones, and cartilage at risk.

But what if we could rejuvenate tissues in aging bodies? What if we could prevent brain diseases by slowing down aging?

In this panel discussion, Gladstone scientists explain how their work on brain, heart, and stem cells have shed new light on the mechanisms of aging, and how this knowledge could one day be harnessed to alleviate and potentially cure age-related diseases.

Speakers

  • Steve Finkbeiner, MD, PhD, Director, Center for Systems and Therapeutics, Gladstone Institutes
  • Casey Gifford, PhD, Staff Scientist, Srivastava Lab, Gladstone Institutes
  • Todd McDevitt, PhD, Senior Investigator, Gladstone Institutes
  • Moderated by Deepak Srivastava, MD, President, Gladstone Institutes

Support Discovery Science

Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.

Donate Now

Up Next


Science in Seconds | Researchers Pinpoint Key Gene Behind Heart Defects in Down Syndrome

Science in Seconds with Deepak Srivastava
Video November 3, 2025

Science in Seconds | Researchers Pinpoint Key Gene Behind Heart Defects in Down Syndrome

In this video, Gladstone scientists share how they used stem cells, gene editing, and AI to identify a gene driving heart defects in Down syndrome—and how reducing its levels in mice restored normal heart development, offering hope for future treatments

Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab AI Big Data CRISPR/Gene Editing Human Genetics Stem Cells/iPSCs

Science in Seconds | The Thinking Microscope: Research Powered by an AI Brain

Science in Seconds featuring Steve Finkbeiner
Video October 15, 2025

Science in Seconds | The Thinking Microscope: Research Powered by an AI Brain

In this video, Steve Finkbeiner and Jeremy Linsley showcase Gladstone’s groundbreaking “thinking microscope”—an AI-powered system that can design, conduct, and analyze experiments autonomously to uncover new insights into diseases like Alzheimer’s, Parkinson’s, and ALS.

Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Neurological Disease Finkbeiner Lab AI Big Data

More News